Ranolazine Loading to Prevent PCI-induced Myocardial Injury
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT01491061
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Registry
-
NCT01491061
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Unknown status
Technical summary
Registry record NCT01491061. Randomized; triple masking; primary purpose treatment. Start 2014-01 (registry gives no type); primary completion 2015-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Ranolazine Loading to Prevent PCI-induced Myocardial Injury
- Acronym
- TWILIGHT
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Ranolazine
- Intervention (Drug)
- Placebo
- Lead sponsor
- University of Roma La Sapienza
Record details
- Record id
cardio:ct-nct01491061- Content hash
244bf238e7a8282f5ef35845bb0a7fb6df8a8396e4858b51e9ea9e6b2a3a9ae0